BE868544A - Composition contenant du dithranol pour le traitement du psoriasis - Google Patents

Composition contenant du dithranol pour le traitement du psoriasis

Info

Publication number
BE868544A
BE868544A BE188911A BE188911A BE868544A BE 868544 A BE868544 A BE 868544A BE 188911 A BE188911 A BE 188911A BE 188911 A BE188911 A BE 188911A BE 868544 A BE868544 A BE 868544A
Authority
BE
Belgium
Prior art keywords
psoriasis
treatment
composition containing
containing dithranol
dithranol
Prior art date
Application number
BE188911A
Other languages
English (en)
Original Assignee
Drythanol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drythanol Ltd filed Critical Drythanol Ltd
Publication of BE868544A publication Critical patent/BE868544A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
BE188911A 1977-07-06 1978-06-28 Composition contenant du dithranol pour le traitement du psoriasis BE868544A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28410/77A GB1574090A (en) 1977-07-06 1977-07-06 Dithranol composition for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
BE868544A true BE868544A (fr) 1978-10-16

Family

ID=10275185

Family Applications (1)

Application Number Title Priority Date Filing Date
BE188911A BE868544A (fr) 1977-07-06 1978-06-28 Composition contenant du dithranol pour le traitement du psoriasis

Country Status (17)

Country Link
US (1) US4203969A (fr)
JP (1) JPS6043329B2 (fr)
AT (1) AT358738B (fr)
AU (1) AU519394B2 (fr)
BE (1) BE868544A (fr)
CA (1) CA1099636A (fr)
CH (1) CH634481A5 (fr)
DE (1) DE2818827C2 (fr)
DK (1) DK152663C (fr)
FR (1) FR2396548A1 (fr)
GB (1) GB1574090A (fr)
GR (1) GR65207B (fr)
IE (1) IE46872B1 (fr)
IT (1) IT1094802B (fr)
NZ (1) NZ187103A (fr)
SE (1) SE432874B (fr)
ZA (1) ZA783771B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316902A (en) * 1979-09-21 1982-02-23 Yu Ruey J Therapeutic compositions and vehicles for topical pharmaceuticals
JPS6056924B2 (ja) * 1981-05-14 1985-12-12 日立建機株式会社 油圧回路
DE3239183A1 (de) * 1981-10-23 1983-05-05 L'Oreal, 75008 Paris Wasserfreies, oxydationsstabiles mittel zur behandlung der haut
FR2520233A1 (fr) * 1982-01-28 1983-07-29 Oreal Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
US5635497A (en) * 1982-06-23 1997-06-03 Yamanouchi Europe B.V. Topical application compositions
US5034420A (en) * 1983-06-09 1991-07-23 Bristol-Myers Squibb Co. Compositions and method for stabilization of anthralin comprising the addition of an oil soluble antioxidant and an anionic surfactant
NZ208338A (en) * 1983-06-09 1987-11-27 Bristol Myers Co Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant
US4551480A (en) * 1983-06-21 1985-11-05 Stiefel Laboratories, Inc. Compositions for the treatment of psoriasis
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
WO1988003799A1 (fr) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Vehicules pharmaceutiques de reduction du flux transdermique
GB8729855D0 (en) * 1987-12-22 1988-02-03 Drythanol Ltd New dithranol compositions
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
US6403123B1 (en) * 2000-09-19 2002-06-11 Eugene J. Van Scott Method for topical treatment of anthralin-responsive dermatological disorders
US20080171795A1 (en) * 2005-03-21 2008-07-17 Life-Care Innovations Pvt. Ltd. Novel Inter and Intra Multilamellar Vesicular Composition
EP3182955B1 (fr) * 2014-08-20 2019-11-20 Amantin Experts Compositions et procédés pour une humidification et une libération contrôlées de principes actifs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3029188A (en) * 1958-02-20 1962-04-10 Olin Mathieson Gelatin adhesive pharmaceutical preparations
US3689667A (en) * 1970-06-24 1972-09-05 Univ California C22 acid and its salts to promote wound healing

Also Published As

Publication number Publication date
AU3555078A (en) 1979-11-01
GR65207B (en) 1980-07-29
AU519394B2 (en) 1981-12-03
SE7804962L (sv) 1979-01-07
US4203969A (en) 1980-05-20
IT1094802B (it) 1985-08-10
DK152663B (da) 1988-04-11
IT7822832A0 (it) 1978-04-28
IE46872B1 (en) 1983-10-19
CA1099636A (fr) 1981-04-21
AT358738B (de) 1980-09-25
SE432874B (sv) 1984-04-30
ATA491378A (de) 1980-02-15
DK152663C (da) 1988-08-22
DE2818827C2 (de) 1983-10-27
NZ187103A (en) 1980-10-24
CH634481A5 (de) 1983-02-15
GB1574090A (en) 1980-09-03
IE780846L (en) 1979-01-06
FR2396548B1 (fr) 1983-04-22
DK186278A (da) 1979-01-07
ZA783771B (en) 1979-07-25
JPS5417114A (en) 1979-02-08
DE2818827A1 (de) 1979-01-18
JPS6043329B2 (ja) 1985-09-27
FR2396548A1 (fr) 1979-02-02

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
BE870055A (fr) Compositions et procede pour le traitement des calculs renaux
BE843359A (fr) Preparation pour le traitement de parodontose
BE884917A (fr) Agent pour le traitement de theilerioses et son application
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
BE828555A (fr) Composition pour le traitement d'infections virales
FR2307909A1 (fr) Compositions pour le traitement des etoffes
SE7804962L (sv) Ditranolkomposition for behandling av psoriasis
BE881208A (fr) Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci
FR2306710A1 (fr) Composition pour le traitement du colon
BE851775A (fr) Composition pour le traitement de la chevelure
FR2333754A1 (fr) Appareil pour le traitement aerobie de boue activee
BE873092A (fr) Composition pour le traitement de l'hypertension
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
BE858692A (fr) Composition pour le traitement de l'acne
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE856957A (fr) Electrode pour traitement d'ionophorese
FR2433978B1 (fr) Traitement d'algues
BE854412A (fr) Compositions pharmaceutiques pour un traitement gynecologique
BE850008A (fr) Traitement de matieres particulaires
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
BE851553A (fr) Traitement de flocons

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DRYTHANOL LTD

Effective date: 19960630